Genomics as a Clinical Decision Support Tool for Identifying and Addressing Modifiable Causes of Cognitive Decline and Improving Outcomes: Proof of Concept Support for This Personalized Medicine Strategy.

Front Aging Neurosci · 2022 · PMC9062132 · PMID 35517054

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Endothelial Nitric Oxide Synthetase and Matrix Metalloprotease Homozygous variants in two highly significant genomic pathways were noted: Endothelial nitric oxide synthetase (NOS3) and matrix metalloprotease (MMP13).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.